The EPS projection of UnitedHealth Group Incorporated (NYSE:UNH) for quarter ended 2016-09-30 is $2.16. Last week, the projection for EPS was $2.16 against target of $2.16, a month earlier. While 2-months ago, this projection was $2.16 versus forecast of $2.16a quarter months earlier, posting a deviation of 0%.
UnitedHealth Group Incorporated (NYSE:UNH) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 10, and 10, correspondingly.
The per-share earnings downgrade for UnitedHealth Group Incorporated (NYSE:UNH) in the preceding 30 and 120 were 0 and 1. While in 60 and 90 days were 0, and 1, in that order.
UnitedHealth Group Incorporated (NYSE:UNH) EPS target was $2.16 for the quarter closed 1. It was based on 13 calls. As on 2016-04-19 the EPS was $1.81. The change was $0.09, posting a deviation of 5.23%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
UnitedHealth Group Incorporated (NYSE:UNH) sales prediction for the fiscal 2017 stands at $49753.038 and the median estimate is at $49435.43. Almost 5 analysts gave sales target.
Among this, the highest sales estimate is $51710.76 while the lowest target is $48221 showing standard deviation of 1290.831%.
As many as 5 analysts have positive sales targets revision while 5 reduced sales estimates, posting a deviation of 0%.
Last month, 5 experts have positive sales number revision. Also, 5 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast, posting a deviation of 1.497%.
1 Chart Pattern Every Investor Should Know